ストックスクリーナーアプリを入手
0.8506
5.49%
-0.0494
アフターアワーズ：
.82
-0.0306
-3.60%
前日終値:
$0.90
開ける：
$0.91
24時間の取引高:
280.07K
Relative Volume:
1.07
時価総額：
$107.44M
収益：
-
当期純損益:
$-70.78M
株価収益率:
-1.5189
EPS:
-0.56
ネットキャッシュフロー:
$-61.27M
1週間 パフォーマンス:
-3.63%
1か月 パフォーマンス:
+20.31%
6か月 パフォーマンス:
+15.02%
1年 パフォーマンス:
-68.61%
1日の値動き範囲:
$0.8197
$0.91
1週間の範囲:
$0.8197
$0.93
52週間の値動き範囲:
$0.62
$3.026
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
名前
Nautilus Biotechnology Inc
セクター
電話
206-333-2001
住所
2701 EASTLAKE AVE EAST, SEATTLE
NAUT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.8506 | 113.67M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-05 | ダウングレード | Goldman | Neutral → Sell |
| 2024-06-27 | 開始されました | Guggenheim | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2022-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-11-02 | 開始されました | Cowen | Outperform |
| 2021-08-04 | 開始されました | Goldman | Neutral |
| 2021-07-13 | 開始されました | Jefferies | Buy |
すべてを表示
Nautilus Biotechnology Inc (NAUT) 最新ニュース
Weiss Ratings Reaffirms Sell (D-) Rating for Nautilus Biotechnology (NASDAQ:NAUT) - MarketBeat
Will Nautilus Biotechnology Inc. price bounce be sustainableJuly 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Should you hold or exit Nautilus Biotechnology Inc. now2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Live market analysis of Nautilus Biotechnology Inc.Market Trend Review & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-09 04:18:13 - newser.com
Will Nautilus Biotechnology Inc. see short term momentumFed Meeting & Reliable Price Action Trade Plans - newser.com
Is Nautilus Biotechnology Inc a good long term investmentMarket Entry Points & Smart Beta Strategies That Actually Work - earlytimes.in
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 - GlobeNewswire
Nautilus Biotechnology, Inc. to Announce Third Quarter 2025 Financial Results on October 28, 2025 - Quiver Quantitative
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences - 富途牛牛
What institutional flow reveals about Nautilus Biotechnology Inc.2025 Institutional Moves & Community Consensus Picks - newser.com
Nautilus Biotechnology Inc. recovery potential after sell offJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
Is now a turning point for Nautilus Biotechnology Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
How sentiment analysis helps forecast Nautilus Biotechnology Inc.Weekly Stock Summary & Verified Entry Point Signals - newser.com
Nautilus Biotechnology Inc. stock daily chart insightsWeekly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Detecting price anomalies in Nautilus Biotechnology Inc. with AI2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Analyzing Nautilus Biotechnology Inc. with multi timeframe chartsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
What analysts say about Nautilus Biotechnology Inc stockFlag and Pennant Patterns & Exceptional Growth Investment - earlytimes.in
Goldman Sachs Group Inc. Has $148,000 Stock Position in Nautilus Biotechnology, Inc. $NAUT - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 3.2% – Here’s Why - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 3.2%Here's Why - MarketBeat
Price momentum metrics for Nautilus Biotechnology Inc. explained2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Nautilus Biotechnology Inc (NAUT) 財務データ
収益
当期純利益
現金流量
EPS
Nautilus Biotechnology Inc (NAUT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Patel Sujal M | CEO, President, and Secretary |
Sep 08 '25 |
Buy |
0.68 |
83,500 |
57,031 |
10,341,721 |
| Murphy Matthew B. | General Counsel |
Sep 04 '25 |
Buy |
0.64 |
20,000 |
12,858 |
74,140 |
| Mowry Anna | CFO and Treasurer |
May 29 '25 |
Buy |
0.77 |
15,000 |
11,488 |
83,000 |
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
5.74%
大文字化:
|
ボリューム (24 時間):